Inventor
WIRTH DAVID D
US21 patents
⚠️ This page may combine multiple inventors who share the name “WIRTH DAVID D”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PHARMACYCLICS LLC
13 patentsUS9296753B2Mar 29, 2016
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC84 citations98
US10125140B1Nov 13, 2018
Crystalline forms of a bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC18 citations97
US9725455B1Aug 8, 2017
Crystalline forms of a bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC25 citations97
US9713617B2Jul 25, 2017
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC28 citations97
US9540382B2Jan 10, 2017
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC43 citations97
US9828383B1Nov 28, 2017
Crystalline forms of a bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC20 citations95
US10294231B2May 21, 2019
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC11 citations92
US10294232B2May 21, 2019
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC9 citations92
US10106548B2Oct 23, 2018
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC13 citations92
US10065968B2Sep 4, 2018
Crystalline forms of a bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC10 citations92
US10961251B1Mar 30, 2021
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC4 citations84
US10752634B2Aug 25, 2020
Crystalline forms of a brutons tyrosine kinase inhibitor
PHARMACYCLICS LLC3 citations84
US10266540B2Apr 23, 2019
Crystalline forms of a Bruton's tyrosine kinase inhibitor
PHARMACYCLICS LLC5 citations84
LILLY CO ELI
6 patentsUS5608043AMar 4, 1997
Process for the preparation of 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose compounds
LILLY CO ELI11 citations74
US5602262AFeb 11, 1997
Process for the preparation of 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
LILLY CO ELI6 citations74
US5559222ASep 24, 1996
Preparation of 1-(2'-deoxy-2',2'-difluoro-D-ribo-pentofuranosyl)-cytosine from 2-deoxy-2,2-difluoro-β-D-ribo-pentopyranose
LILLY CO ELI11 citations74
US4703118AOct 27, 1987
Synthesis of 3-iodomethyl cephalosporins
LILLY CO ELI11 citations65
US5635613AJun 3, 1997
Process for preparing crystal forms and solvates of dirithromycin
LILLY CO ELI3 citations59
US5021564AJun 4, 1991
Process for preparing ceftazidime pentahydrate
LILLY CO ELI0 citations52